Fig. 2From: Early evaluation of liver metastasis using spectral CT to predict outcome in patients with colorectal cancer treated with FOLFOXIRI and bevacizumabA, B. OS in CRLM patients stratified by IoD = 5.93 (100ug/cm3). C, D. OS in CRLM patients stratified by CS = 0.37. E, F. OS in CRLM patients stratified by CEA = 31.7 (ng/mL). G, H. OS in CRLM patients stratified by BLD = 25.77 mmBack to article page